Atlas Trials

Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

Clinical trial NCT00534417 · COMPLETED

Trial details

NCT number
NCT00534417
Sponsor
Accelerated Community Oncology Research Network
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2007-10-01
Primary completion
2011-09-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.